Cefpodoxime
Third-Generation Cephalosporins
- Drug class
- Third-Generation Cephalosporins
- Availability
- See label
- Markets covered
- 1
- Products on record
- 2
Overview
Cefpodoxime is an active pharmaceutical ingredient in the Third-Generation Cephalosporins group (J01DD). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 2 | February 20, 2026 |
GBUnited Kingdom· MHRA
2 products
Uses
Cefpodoxime proxetil is indicated for the treatment of the following infections when caused by susceptible organisms. - Sinusitis - Tonsillitis and pharyngitis In the above indications, cefpodoxime should be reserved for recurrent or chronic infections, or for infections where the causative organism is known or suspected to be resistant to commonly used antibiotics or in case the commonly used antibiotic cannot be used for any reason.
1) . Consideration should be given to official guidance on the appropriate use of antibacterial agents.
How to take
Drug interactions
Known interactions involving Cefpodoxime. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL044161586 · revised February 20, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.